Round 1 Winners!
Proof of Usefulness Report

Veripad Inc.

Analysis completed on 3/20/2026

-16.6
Proof of Usefulness Score
Lab Mode

The submission addresses a genuine real-world problem (counterfeit medication) using valid technical concepts, but it contains severe red flags. The claimed metrics ('everyone' for reach, 'most people have used my product' for traction, and 'all time marketcap' for monthly revenue) are nonsensical and verifiably false, indicating zero actual traction, an inactive product, and exceptionally poor submission quality.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+62.5
Audience Reach Impact-20.0
Technical Innovation+45.0
Evidence Of Traction-100.0
Market Timing Relevance+15.0
Functional Completeness-20.0
Subtotal-17.5
Usefulness Multiplierx0.95
Final Score-17

Project Details

Project URL
Description
We are a disruptive biotech startup that is leveraging mobile technology to reduce moralities from counterfeit medication. In certain regions, up to 20-50% of medications are counterfeit. Counterfeit medications may not only lead to serious health hazards but also greater socioeconomic impacts for patients. Our team is working to bring affordable and accurate technological solutions to low- and middle- income countries. We have designed a novel software that incorporates machine learning and computer vision to analyze the results of comprehensive test cards to truly democratize drug authentication.

Algorithm Insights

Market Position
Early stage requiring focused development
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline